Mitsuyoshi Yoshimoto

Kashiwa, 2778577, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications

Mass Measurements of Exotic ^{48-50}Ar Isotopes: Probing Proton-Neutron Interaction of the Doubly Magic ^{52}Ca and the Robustness of N=32 Subshell.

Mass Measurements of Exotic ^{48-50}Ar Isotopes: Probing Proton-Neutron Interaction of the Doubly Magic ^{52}Ca and the Robustness of N=32 Subshell.

Journal: Physical review letters
Published: January 19, 2026

First-in-human phase I study of hypoxia-targeting 64Cu-ATSM radioligand therapy in patients with malignant brain tumors (STAR-64).

First-in-human phase I study of hypoxia-targeting 64Cu-ATSM radioligand therapy in patients with malignant brain tumors (STAR-64).

Journal: ESMO open
Published: January 04, 2026

β-Decay Half-Lives of Neutron-Rich Sulfur to Potassium: Evolution of the N=32 and 34 Subshell Closures below Calcium.

β-Decay Half-Lives of Neutron-Rich Sulfur to Potassium: Evolution of the N=32 and 34 Subshell Closures below Calcium.

Journal: Physical review letters
Published: June 04, 2025

Enhanced Radionuclide Therapy via the Conjugation of Pentadecanoic Acids With 225Ac- and 177Lu-Labeled RGD Peptides.

Enhanced Radionuclide Therapy via the Conjugation of Pentadecanoic Acids With 225Ac- and 177Lu-Labeled RGD Peptides.

Journal: Cancer science
Published: May 26, 2025

Precision Mass Measurements around ^{84}Mo Rule Out ZrNb Cycle Formation in the Rapid Proton-Capture Process at Type I X-Ray Bursts.

Precision Mass Measurements around ^{84}Mo Rule Out ZrNb Cycle Formation in the Rapid Proton-Capture Process at Type I X-Ray Bursts.

Journal: Physical review letters
Published: April 18, 2025

Long-Term Therapeutic Effects of 225Ac-DOTA-E[c(RGDfK)]2 Induced by Radiosensitization via G2/M Arrest in Pancreatic Ductal Adenocarcinoma.

Long-Term Therapeutic Effects of 225Ac-DOTA-E[c(RGDfK)]2 Induced by Radiosensitization via G2/M Arrest in Pancreatic Ductal Adenocarcinoma.

Journal: Pharmaceutics
Published: November 29, 2024

αvβ3 integrin-targeted magnetic resonance imaging in a pancreatic cancer mouse model using RGD-modified liposomes encapsulated with Fe-deferoxamine.

αvβ3 integrin-targeted magnetic resonance imaging in a pancreatic cancer mouse model using RGD-modified liposomes encapsulated with Fe-deferoxamine.

Journal: PloS one
Published: June 10, 2024

Precise Spectroscopy of the 3n and 3p Systems via the ^{3}H(t, ^{3}He)3n and ^{3}He(^{3}He, t)3p Reactions at Intermediate Energies.

Precise Spectroscopy of the 3n and 3p Systems via the ^{3}H(t, ^{3}He)3n and ^{3}He(^{3}He, t)3p Reactions at Intermediate Energies.

Journal: Physical review letters
Published: January 10, 2024

The safe handling of 211At compounds.

The safe handling of 211At compounds.

Journal: Annals of nuclear medicine
Published: June 21, 2022

In Vitro Tumor Cell-Binding Assay to Select High-Binding Antibody and Predict Therapy Response for Personalized 64Cu-Intraperitoneal Radioimmunotherapy against Peritoneal Dissemination of Pancreatic Cancer: A Feasibility Study.

In Vitro Tumor Cell-Binding Assay to Select High-Binding Antibody and Predict Therapy Response for Personalized 64Cu-Intraperitoneal Radioimmunotherapy against Peritoneal Dissemination of Pancreatic Cancer: A Feasibility Study.

Journal: International journal of molecular sciences
Published: April 20, 2022

Evaluation of Aminopolycarboxylate Chelators for Whole-Body Clearance of Free 225Ac: A Feasibility Study to Reduce Unexpected Radiation Exposure during Targeted Alpha Therapy.

Evaluation of Aminopolycarboxylate Chelators for Whole-Body Clearance of Free 225Ac: A Feasibility Study to Reduce Unexpected Radiation Exposure during Targeted Alpha Therapy.

Journal: Pharmaceutics
Published: September 09, 2021

Usefulness of PET-guided surgery with 64Cu-labeled cetuximab for resection of intrapancreatic residual tumors in a xenograft mouse model of resectable pancreatic cancer.

Usefulness of PET-guided surgery with 64Cu-labeled cetuximab for resection of intrapancreatic residual tumors in a xenograft mouse model of resectable pancreatic cancer.

Journal: Nuclear medicine communications
Published: June 08, 2021
Showing 1-12 of 36

Last Updated: 09/26/2026